QA: OPKO Health INC in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000944809_2019_OPKO_Health_INC.pdf

Logs

warning Large missing amount for aggregate "Expenses" added to remainder. industry.us_generic {'missing_ratio': 1.1670234182138233, 'aggregate_val': 1122737000, 'exp_sum': 518101000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 358346000, 'ResearchAndDevelopmentExpense': 125586000, 'remainder_Expenses': 34169000}}
warning Large missing amount for aggregate "Expenses" added to remainder. industry.us_generic {'missing_ratio': 0.9376329715361068, 'aggregate_val': 1183047000, 'exp_sum': 610563000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 343305000, 'ResearchAndDevelopmentExpense': 117870000, 'remainder_Expenses': 149388000}}

Graph

Absolute values for 0000944809, OPKO Health INC

  xvar xval
0 AssetsCurrent 317,731,000
1 IntangibleAssetsNetIncludingGoodwill 1,314,645,000
2 PropertyPlantAndEquipmentNet 144,674,000
3 remainder_Assets 674,022,000
4 LiabilitiesCurrent 288,321,000
5 LiabilitiesNoncurrent 371,460,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 240,948,999
9 ResearchAndDevelopmentExpense 126,598,630
10 remainder_Expenses 639,476,532
11 remainder_Revenues 962,480,586
12 remainder_NetIncome -17,982,244
13 remainder_ComprehensiveNetIncome 26,240,414
  yvar yval
0 Assets 2,451,072,000
1 Liabilities 659,781,000
2 Expenses 1,007,024,161
3 Revenues 962,480,586
4 StockholdersEquity 1,791,291,000
5 NetIncome -62,525,819
6 ComprehensiveNetIncome -49,405,612
7 BaseVar 2,562,290,202
8 EconomicCapitalRatiobeforeLimitedLiability 2.48
9 EconomicCapitalRatio 3.34

Edgar->Model Mapping

Feature Distribution

Change over Time